Name | dl-laudanosine |
---|---|
Synonyms |
(R)-Laudanosine
LAUDANOSINE,DL-(SH) (+/-)-LAUDANOSIDE (+-)-laudanosine LAUDANOSINE,DL-(SH)(CALL) LAUDANOSINE,DL DL-LAUDANOSIDE |
Description | DL-Laudanosine, an Atracurium and Cisatracurium metabolite, crosses the blood–brain barrier and may cause excitement and seizure activity[1]. |
---|---|
Related Catalog | |
In Vivo | DL-Laudanosine (Laudanosine) appears to be unique in its ability to produce cerebral stimulation in lightly anaesthetized animals and it is reported to cause arousal from anaesthesia in subconvulsive doses[1]. Animal Model: Male CFLP mice weighing 18-25 g, and male Wistar rats weighing 120-150 g [2]. Dosage: 10-20 mg/kg. Administration: IV. Result: Caused convulsions and hind limb extensions. |
References |
Melting Point | 115℃ |
---|---|
Molecular Formula | C21H27NO4 |
Molecular Weight | 357.44300 |
Exact Mass | 357.19400 |
PSA | 40.16000 |
LogP | 3.43060 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS06 |
---|---|
Signal Word | Danger |
Hazard Statements | H301 + H311 + H331 |
Precautionary Statements | Missing Phrase - N15.00950417-P261-P280-P302 + P352 + P312-P304 + P340 + P312-P403 + P233 |
Risk Phrases | 26/28-40 |
Safety Phrases | 22-24/25 |
RIDADR | UN 2810 |
HS Code | 2933499090 |
Precursor 0 | |
---|---|
DownStream 9 | |
HS Code | 2933499090 |
---|---|
Summary | 2933499090. other compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |